TreVita, a U.S.-based medical travel company, announced on August 4, 2026, the launch of its new hair transplant offering in Zona Rio, Mexico, just 20 minutes south of San Diego. This expansion marks the latest addition to TreVita's growing portfolio of premium medical travel services, which aim to remove barriers for Americans seeking specialized care abroad.
The new service utilizes follicular unit extraction (FUE), an advanced technology designed to minimize trauma to follicular grafts while supporting natural-looking, permanent results. Procedures are performed by world-class physicians in Zona Rio, many with over 20 years of experience, and are coordinated by TreVita's U.S.-based team, which manages consultations, accommodations, transportation, and recovery support throughout the client journey.
Demand for hair restoration services is accelerating globally. According to Grand View Research, the global hair restoration and transplant market is projected to grow nearly 90% by 2030, with North America already accounting for more than 32% of the global market. As more Americans seek specialized hair transplant services, TreVita believes patients are increasingly looking for internationally recognized expertise without the need for long-haul travel, offering a premium medical travel experience just 20 minutes south of San Diego.
“Our goal has never been to simply help people travel for healthcare,” said Blake Schroeder, CEO of TreVita. “We're building a company that raises the standard for what medical travel should look like. That means partnering with exceptional physicians, developing long-term clinical partnerships, investing in our own care infrastructure, carefully vetting every aspect of the patient experience, and surrounding clients with support before, during and after treatment. Hair transplant is just another step toward building a broader platform focused on healthspan, regenerative medicine and the future of accessible, innovative healthcare.”
The launch represents another step in TreVita's mission to make world-class medical care more accessible for Americans seeking treatments that are cost-prohibitive, difficult to access, not covered by traditional insurance, or unavailable in the United States. Rather than simply connecting clients with physicians, TreVita manages the entire experience, from initial consultation and attractive financing to travel coordination, accommodations, and post-procedure support.
Founded in 2022 and headquartered in San Diego, TreVita was created in response to a growing gap between the healthcare Americans want and the care many are able to access through the traditional healthcare system. The company began by helping clients pursue bariatric procedures abroad and has since expanded into plastic surgery, regenerative medicine, including stem cell therapies, and other specialty services, building a reputation around physician vetting, concierge-level coordination, and long-term client support.
Unlike many referral services, TreVita is a long-term care partner. The company helps clients evaluate providers, coordinate every aspect of their medical travel experience, and remain supported well beyond their procedure. Medical decisions and treatments remain under the direction of independent physician partners, while TreVita serves as the trusted guide throughout the journey.
Hair transplant services represent the latest addition to what TreVita sees as a much broader future. The company is building a premium medical travel platform centered on healthspan, helping people gain greater access to innovative care that supports healthier, more active lives over the long term. As TreVita continues to expand into new specialties and emerging technologies, it remains committed to the principles that have guided the company from the beginning: safety, caring for people, and integrity. TreVita defines that vision as creating “a world where healthspan is maximized and lives are changed positively.”
TreVita's Hair Transplant Services are now available to qualifying clients through the company's U.S.-based care consultant team. To make treatment accessible, the company offers flexible financing options with a financing approval rate of more than 99% for qualified applicants.
